期刊文献+

儿童化疗方案加甲磺酸伊马替尼治疗Bcr-abl融合基因阳性的成人急性淋巴细胞性白血病

下载PDF
导出
摘要 目的分析儿童化疗方案加甲磺酸伊马替尼治疗成人bcr/abl融合基因阳性急性淋巴细胞白血病(ALL)患者的缓解率及长期生存状态。方法10例患者,中位年龄30岁(19-71岁)岁,经MICM分型确诊为bcr-abl阳性ALL。均予BFM90方案化疗加甲磺酸伊马替尼治疗。结果所有患者均获得完全缓解,中位随访时间为20月(4-24月),6例患者持续CR。3例获得完全的细胞遗传学缓解。结论化疗方案加甲磺酸伊马替尼可以明显提高bcr/abl融合基因阳性ALL患者预后。
出处 《西南军医》 2009年第6期1053-1054,共2页 Journal of Military Surgeon in Southwest China
  • 相关文献

参考文献7

  • 1Faderl S,Kantarjian H M,Talpaz M,et al.Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia[].Blood.1998 被引量:1
  • 2Schrappe M,Reiter A,Ludwig WD,et al.Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group[].Blood.2000 被引量:1
  • 3Gokbuget,N.,Hoelzer,D.,Arnold,R.Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)[].Hematology Oncology Clinics of North America.2000 被引量:1
  • 4Faderl,S.,Kantarjian,H.M.,Thomas,D.A.Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia[].Leukemia and Lymphoma.2000 被引量:1
  • 5I Avivi,AH. Goldstone.Bone marrow transplant in Ph+ ALL patients[].Bone Marrow Transplantation.2003 被引量:1
  • 6H Dombret,J Gabert,JM Boiron.Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia- results of prospective multicenter LALA-94 trial[].Blood.2002 被引量:1
  • 7S Lee,YJ Kim,CK Min.The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia[].Blood.2005 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部